Determination of the optimal screen interval in low-dose CT lung cancer screening: Are we there yet?

Translational Cancer Research

Volumn 5, Issue , 2016, Pages S1070-S1072

  Heuvelmans, Marjolein A ^a,b   Oudkerk, Matthijs ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; HUMAN; LUNG CANCER; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); THORAX RADIOGRAPHY;

EID: 85009966212     PISSN: 2218676X     EISSN: 22196803     Source Type: Journal    
DOI: 10.21037/tcr.2016.11.55     Document Type: Editorial

References (13)

1. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
2. Detterbeck FC, Mazzone PJ, Naidich DP, et al. Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:e78S-92S.
3. Wender R, Fontham ET, Barrera E Jr, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 2013;63:107-17.
4. Humphrey LL, Deffebach M, Pappas M, et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation. Ann Intern Med 2013;159:411-20.
5. U.S. Preventive Services Task Force. Lung Cancer: Screening. 2013. Available online: https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/lung-cancer-screening
6. Swensen SJ, Jett JR, Sloan JA, et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002;165:508-13.
7. Walter JE, Heuvelmans MA, de Jong PA, et al. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial. Lancet Oncol 2016;17:907-16.
8. Yousaf-Khan U, van der Aalst C, de Jong PA, et al. Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval. Thorax 2016. pii: thoraxjnl-2016-208655. [Epub ahead of print].
9. Pastorino U, Rossi M, Rosato V, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 2012;21:308-15.
10. Patz EF Jr, Greco E, Gatsonis C, et al. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. Lancet Oncol 2016;17:590-9.
11. Sverzellati N, Silva M, Calareso G, et al. Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen. Eur Radiol 2016;26:3821-3829.
12. Oudkerk M, Heuvelmans MA. Screening for lung cancer by imaging: the Nelson study. JBR-BTR 2013;96:163-6.
13. Horeweg N, van Rosmalen J, Heuvelmans MA, et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol 2014;15:1332-41.